# Neoadjuvant Nivolumab in Glioblastoma

> **NCT02550249** · PHASE2 · COMPLETED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 29 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** Nivolumab

## Key facts

- **NCT ID:** NCT02550249
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2017-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02550249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02550249, "Neoadjuvant Nivolumab in Glioblastoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02550249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*